Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Hematology · Antiphospholipid Syndrome

How Do Blood Thinners Affect Lupus Anticoagulant Testing?

At a Glance

Warfarin, heparin, and DOACs can interfere with lupus anticoagulant tests, causing false-positive, false-negative, or unreliable results. Anticardiolipin and anti-beta-2 glycoprotein I tests are usually less affected, but anticoagulation should never be stopped without specialist guidance.

In this answer

4 sections

01

Why Anticoagulants Interfere with Lupus Anticoagulant Tests

02

Do Blood Thinners Affect All APS Tests?

03

How Doctors Navigate LA Testing While You’re on Medication

04

A Crucial Warning About Stopping Your Medication

If you are already taking a blood thinner like warfarin, heparin, or a direct oral anticoagulant (DOAC), it will directly interfere with a lupus anticoagulant (LA) test. Because the lupus anticoagulant test measures how long it takes for your blood to clot in a test tube, medications designed to prevent clotting can skew the results. These drugs can cause both false-positive (showing you have the antibody when you don’t) and false-negative (hiding the antibody when you actually have it) results [1][2]. While careful coordination between your doctor and the laboratory can help reduce this interference, no strategy is perfect, and sometimes a reliable lupus anticoagulant test simply cannot be performed while you are on medication [1].

Why Anticoagulants Interfere with Lupus Anticoagulant Tests

Lupus anticoagulant testing relies on functional, clot-based tests (often called the dRVVT or aPTT tests). In a laboratory, technicians measure the time it takes for a sample of your blood to form a clot when certain chemicals are added.

Blood thinners interfere with these tests in different ways:

Medication Type How It Affects Testing Can the Lab Fix the Interference?
Warfarin (Coumadin) Reduces clotting factors, artificially prolonging the test times [3][4]. No. There is no chemical neutralizer for warfarin. The lab must interpret results cautiously alongside your INR [4].
DOACs (e.g., rivaroxaban, apixaban, dabigatran) Strong interference. Can create unpredictable false-positive or false-negative patterns even at very low levels [5][6]. Sometimes. The lab can use specialized chemical filters (like DOAC-Stop), but residual drug often remains and can still skew results [7][8].
Heparins (UFH and LMWH) Slows down the laboratory clotting process [9]. Sometimes. Many test chemicals contain built-in heparin neutralizers, but they only work up to a certain medication limit [9].

Do Blood Thinners Affect All APS Tests?

No. A diagnosis of antiphospholipid syndrome (APS) relies on testing for three specific types of antibodies. While the lupus anticoagulant test is easily disrupted by blood thinners, the other two tests are generally not:

  • Anticardiolipin antibodies (aCL)
  • Anti-beta-2 glycoprotein I antibodies (anti-β2GPI)

These two tests use a different laboratory method that looks for the physical presence of the antibodies rather than measuring how your blood clots [2][10]. Because they do not rely on a clotting reaction, you can usually have aCL and anti-β2GPI tests performed without stopping your anticoagulation [11][2].

Important Note on Diagnosis: A single positive antibody test does not mean you have APS. To confirm a diagnosis, your doctor must see persistent antibody positivity. This means any positive test must be repeated and remain positive at least 12 weeks later [2][12].

How Doctors Navigate LA Testing While You’re on Medication

Because blood thinners distort the results, the preferred approach is to test for LA before you start anticoagulant therapy [1]. However, you should never delay life-saving treatment just to get a test.

If your doctor needs to check your lupus anticoagulant status while you are already on medication, they may use one of these specialized strategies:

  • Trough Level Sampling: Your doctor may instruct you to have your blood drawn at the “trough” level—the time right before your next scheduled dose when the amount of medication in your blood is at its lowest [9][1]. However, even at trough levels, DOACs can still cause false results [5].
  • Laboratory Neutralizers: Modern laboratories can use specialized chemicals or filters to neutralize the blood thinner in your specific blood sample before running the test [7][9]. These products do not guarantee an accurate result, as they may leave residual drug or alter the test in other ways [8].
  • Temporary Specialist-Directed Medication Changes: In rare cases, a specialist may temporarily switch you from a DOAC or warfarin to low-molecular-weight heparin (LMWH) injections [1]. This is a highly complex process called “bridging” that carries bleeding and clotting risks. It does not guarantee an interpretable LA result because LMWH can still interfere with the tests [9]. This is not a routine step just to obtain a test.

Because none of these strategies are perfect, a specialized coagulation laboratory may ultimately report the LA result as “uninterpretable” due to medication interference.

A Crucial Warning About Stopping Your Medication

Never stop taking your blood thinners or change your dose on your own just to get a “clean” lab test.

Whether or not you have APS, stopping your anticoagulation abruptly or managing it poorly can trigger severe, life-threatening clotting events [13]. Any temporary pause or medication switch for testing must be meticulously planned and monitored by a prescribing specialist.

Safety Box: Managing Your Medication

  • If you miss a dose, take an accidental extra dose, or experience unusual bleeding, contact your doctor or pharmacist immediately. Do not try to self-correct your doses.
  • Seek emergency medical care if you develop symptoms of a new clot (such as sudden shortness of breath, chest pain, new leg swelling, or one-sided weakness) or severe, uncontrolled bleeding.

Checklist for Your Blood Draw

To give the laboratory the best chance of interpreting your results accurately, follow these steps on the day of your blood test:

  • Bring your medication details: Know the exact name and dose of the blood thinner you take.
  • Know your timing: Tell the laboratory the exact time you took your last dose.
  • Follow instructions: Do not skip or delay a dose unless specifically instructed to do so by your prescribing doctor.
  • Ask questions: Ask if the lab has validated methods for handling your specific medication, or if they will measure residual drug levels.

Common questions in this guide

Can I get a lupus anticoagulant test while taking a blood thinner?
Sometimes, but the result may not be reliable. Warfarin, heparin, and DOACs can change clot-based test results and may lead to a false-positive, false-negative, or uninterpretable finding. A specialized laboratory and your clinician must decide whether the result can be interpreted.
How does warfarin affect lupus anticoagulant testing?
Warfarin lowers clotting factors and can make clotting tests take longer than they otherwise would. There is no laboratory neutralizer that reliably removes warfarin's effect, so results must be interpreted cautiously with the INR. Do not stop warfarin just to prepare for testing.
Do DOACs such as apixaban or rivaroxaban interfere with the test?
Yes. DOACs can strongly affect lupus anticoagulant testing and may cause false-positive or false-negative patterns even when the drug level is low. Testing at the lowest drug level or using a laboratory filter may reduce interference, but neither approach guarantees an accurate result.
Can heparin make a lupus anticoagulant test inaccurate?
Unfractionated heparin and low-molecular-weight heparin can slow the clotting reaction measured by the test. Some test reagents contain heparin neutralizers, but they work only within a limited range, so interference may remain. The laboratory needs to know which heparin product you use and when you last received it.
Are anticardiolipin and anti-beta-2 glycoprotein I tests affected by blood thinners?
These tests are usually less affected because they look for the antibodies directly rather than measuring how quickly blood clots. They can often be performed without stopping anticoagulation. A single positive result does not confirm APS; it must remain positive when repeated at least 12 weeks later.
Should I skip or stop my blood thinner before lupus anticoagulant testing?
No. Never stop or change an anticoagulant on your own to obtain a cleaner test result. Abruptly stopping treatment or taking doses incorrectly can cause serious or life-threatening clots. Any temporary pause or switch must be planned and monitored by the prescribing specialist.
How should I prepare for a lupus anticoagulant blood draw?
Bring the exact name and dose of your blood thinner, and tell the laboratory when you last took it. Take your medicine as prescribed unless your clinician specifically gives different instructions; a clinician may schedule a draw near the lowest drug level, but this does not eliminate DOAC interference. Ask whether the laboratory has a validated method for your medication or can measure residual drug interference.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can we rely on the anticardiolipin and anti-beta-2 glycoprotein I tests instead of the lupus anticoagulant test right now?
  2. 2.Does the laboratory you use have validated neutralizers for my specific medication?
  3. 3.Should I schedule my blood draw for a specific time of day relative to when I take my medication?
  4. 4.How will we know if the test result was skewed by my medication or if it is accurate?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Are DOACs Safe in Familial APS or Is Warfarin Better?Can I Have APS If Standard Tests Are Negative? ExplainedDo I Need Blood Thinners for Long-Distance Travel With APS?Do People With Familial APS Need Lifelong Warfarin?How Common Is Familial APS Compared With Sporadic APS?How Do I Interpret Antiphospholipid IgG and IgM Levels?What If I Get Another Clot on Warfarin With INR in Range?How Should Surgery and Hospitalization Be Managed With APS?Is Antiphospholipid Syndrome Inherited? Risk to ChildrenIs There a Genetic Test for Familial APS? What to KnowShould I Take Daily Low-Dose Aspirin for APS Antibodies?Familial APS: Should You Check for Lupus and Kidney Disease?What Clinical Events Count Toward an APS Diagnosis?What Tests and Follow-Up Does Established APS Require?What Is the Difference Between APS Criteria and Diagnosis?What Do Single, Double, and Triple-Positive APS Mean?What Is Your Clot Risk With Antiphospholipid Antibodies?Positive Antiphospholipid Antibody Test: What to Do NextWhy Must APS Antibody Tests Be Repeated 12 Weeks Apart?

References

References (13)
  1. 1

    Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants.

    Favaloro EJ, Pasalic L

    Research and practice in thrombosis and haemostasis 2022; (6(2)):e12676 doi:10.1002/rth2.12676.

    PMID: 35316943
  2. 2

    Testing for the lupus anticoagulant: the good, the bad, and the ugly.

    Favaloro EJ, Pasalic L, Selby R

    Research and practice in thrombosis and haemostasis 2024; (8(3)):102385 doi:10.1016/j.rpth.2024.102385.

    PMID: 38623474
  3. 3

    Clinical usefulness of the dilute Russell viper venom time test for patients taking warfarin.

    Kanouchi K, Narimatsu H, Ohnuma O, et al.

    International journal of hematology 2017; (106(2)):206-211 doi:10.1007/s12185-017-2228-y.

    PMID: 28390037
  4. 4

    Mixing studies in lupus anticoagulant testing are required at least in some type of samples.

    Devreese KM, de Laat B

    Journal of thrombosis and haemostasis : JTH 2015; (13(8)):1475-8 doi:10.1111/jth.13020.

    PMID: 26017873
  5. 5

    Lupus-anticoagulant testing at NOAC trough levels.

    Ratzinger F, Lang M, Belik S, et al.

    Thrombosis and haemostasis 2016; (116(2)):235-40 doi:10.1160/TH16-02-0081.

    PMID: 27075441
  6. 6

    Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives.

    Favaloro EJ, Mohammed S, Curnow J, Pasalic L

    Pathology 2019; (51(3)):292-300 doi:10.1016/j.pathol.2018.11.008.

    PMID: 30665674
  7. 7

    The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants.

    Ząbczyk M, Kopytek M, Natorska J, Undas A

    Clinical chemistry and laboratory medicine 2019; (57(9)):1374-1381 doi:10.1515/cclm-2018-1197.

    PMID: 30763261
  8. 8

    Direct oral anticoagulant adsorption: Impact on lupus anticoagulant testing-Review of the literature and evaluation on spiked and patient samples.

    De Kesel PM, Devreese KMJ

    Journal of thrombosis and haemostasis : JTH 2020; (18(8)):2003-2017 doi:10.1111/jth.14894.

    PMID: 32400112
  9. 9

    Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis.

    Tripodi A, Cohen H, Devreese KMJ

    Journal of thrombosis and haemostasis : JTH 2020; (18(7)):1569-1575 doi:10.1111/jth.14846.

    PMID: 32619349
  10. 10

    Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances.

    Vandevelde A, Devreese KMJ

    Journal of clinical medicine 2022; (11(8)) doi:10.3390/jcm11082164.

    PMID: 35456258
  11. 11

    Antiphospholipid Antibody Testing for Anti-cardiolipin and Anti-β2 Glycoprotein I Antibodies Using Chemiluminescence-Based Panels.

    Favaloro EJ, Mohammed S, Vong R, Pasalic L

    Methods in molecular biology (Clifton, N.J.) 2023; (2663()):297-314 doi:10.1007/978-1-0716-3175-1_19.

    PMID: 37204719
  12. 12

    Cardiac Manifestations of Antiphospholipid Syndrome: Clinical Presentation, Role of Cardiac Imaging, and Treatment Strategies.

    Tufano A, Di Minno MND, Guida A, et al.

    Seminars in thrombosis and hemostasis 2019; (45(5)):468-477 doi:10.1055/s-0039-1692702.

    PMID: 31216589
  13. 13

    Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients.

    Stammler R, Nguyen Y, Yelnik C, et al.

    Journal of thrombosis and haemostasis : JTH 2023; (21(5)):1258-1265 doi:10.1016/j.jtha.2023.02.007.

    PMID: 36792010

This page is for informational purposes only and does not constitute medical advice. Ask your prescribing clinician and the laboratory specialist how your anticoagulant may affect APS testing, and never stop or change it without medical guidance.

Get notified when new evidence is published on familial antiphospholipid syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.